106 related articles for article (PubMed ID: 35467610)
1. Serum Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Levels Are Decreased in Children with Attention-Deficit/Hyperactivity Disorder.
Işık Ü; Kılıç F; Demirdaş A; Aktepe E; Aydoğan Avşar P
Psychiatr Danub; 2022; 34(1):51-56. PubMed ID: 35467610
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder.
Işık Ü; Bilgiç A; Toker A; Kılınç I
Psychiatry Res; 2018 Mar; 261():212-219. PubMed ID: 29324397
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of tumour necrosis factor-like weak inducer of apoptosis in children with autism spectrum disorder.
Artık A; Öztelcan Gündüz B; Mızrak S; Işık Ü
Int J Dev Disabil; 2023; 69(4):611-616. PubMed ID: 37346259
[No Abstract] [Full Text] [Related]
4. Serum Galectin-3 Levels in Children with Attention-Deficit/Hyperactivity Disorder.
Isık Ü; Kılıç F; Demirdas A; Aktepe E; Aydogan Avsar P
Psychiatry Investig; 2020 Mar; 17(3):256-261. PubMed ID: 32151128
[TBL] [Abstract][Full Text] [Related]
5. Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia.
Kiliç F; Işik Ü; Usta A; Demirdaş A
Braz J Psychiatry; 2021; 43(3):242-246. PubMed ID: 32785454
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
7. Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder.
Aydoğan Avşar P; Işık Ü; Aktepe E; Kılıç F; Doğuç DK; Büyükbayram Hİ
Int J Psychiatry Clin Pract; 2021 Mar; 25(1):49-55. PubMed ID: 32757874
[TBL] [Abstract][Full Text] [Related]
8. Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample.
Krakowski AD; Cost KT; Anagnostou E; Lai MC; Crosbie J; Schachar R; Georgiades S; Duku E; Szatmari P
Mol Autism; 2020 Apr; 11(1):28. PubMed ID: 32334619
[TBL] [Abstract][Full Text] [Related]
9. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
Bilgiç A; Toker A; Işık Ü; Kılınç İ
Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
[TBL] [Abstract][Full Text] [Related]
10. Changed Plasma Levels of Zinc and Copper to Zinc Ratio and Their Possible Associations with Parent- and Teacher-Rated Symptoms in Children with Attention-Deficit Hyperactivity Disorder.
Viktorinova A; Ursinyova M; Trebaticka J; Uhnakova I; Durackova Z; Masanova V
Biol Trace Elem Res; 2016 Jan; 169(1):1-7. PubMed ID: 26063047
[TBL] [Abstract][Full Text] [Related]
11. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder.
Arnold LE; Bozzolo H; Hollway J; Cook A; DiSilvestro RA; Bozzolo DR; Crowl L; Ramadan Y; Williams C
J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):628-36. PubMed ID: 16190794
[TBL] [Abstract][Full Text] [Related]
12. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Percinel I; Yazici KU; Ustundag B
Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
[TBL] [Abstract][Full Text] [Related]
13. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.
Leslie LK; Weckerly J; Plemmons D; Landsverk J; Eastman S
Pediatrics; 2004 Jul; 114(1):129-40. PubMed ID: 15231919
[TBL] [Abstract][Full Text] [Related]
14. No Tryptophan, Tyrosine and Phenylalanine Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder.
Bergwerff CE; Luman M; Blom HJ; Oosterlaan J
PLoS One; 2016; 11(3):e0151100. PubMed ID: 26938936
[TBL] [Abstract][Full Text] [Related]
15. Relationships between behavioral symptoms of non-medicated Chinese children with attention deficit hyperactivity disorder and parenting stress: Comparison of different subtypes and comorbidities.
Li Y; Jiang WQ; Du YS; Coghill D
Asia Pac Psychiatry; 2016 Jun; 8(2):127-35. PubMed ID: 26403485
[TBL] [Abstract][Full Text] [Related]
16. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
[TBL] [Abstract][Full Text] [Related]
17. Attention deficit hyperactivity disorder and autism spectrum disorder symptoms in school-age children born very preterm.
Bröring T; Oostrom KJ; van Dijk-Lokkart EM; Lafeber HN; Brugman A; Oosterlaan J
Res Dev Disabil; 2018 Mar; 74():103-112. PubMed ID: 29413425
[TBL] [Abstract][Full Text] [Related]
18. Tumor Necrosis Factor-like Weak Inducer of Apoptosis: A Novel Serum Marker in Patients with Severe Alopecia.
Al Taweel AI; Hamed AM; Abdelrahman AMN; Hassan MNI
Int J Trichology; 2019; 11(3):113-117. PubMed ID: 31360039
[TBL] [Abstract][Full Text] [Related]
19. Do parents and children agree on rating a child's HRQOL? A systematic review and Meta-analysis of comparisons between children with attention deficit hyperactivity disorder and children with typical development using the PedsQL
Lee YC; Yang HJ; Lee WT; Teng MJ
Disabil Rehabil; 2019 Feb; 41(3):265-275. PubMed ID: 29057670
[TBL] [Abstract][Full Text] [Related]
20. Attention-deficit/hyperactivity disorder developmental trajectories related to parental expressed emotion.
Musser ED; Karalunas SL; Dieckmann N; Peris TS; Nigg JT
J Abnorm Psychol; 2016 Feb; 125(2):182-195. PubMed ID: 26854504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
